GSMA
10.9.2019 04:02:10 CEST | Business Wire | Press release
The GSMA today announced the first speakers for the 2019 Mobile 360 Series – Digital Societies conference, which will take place 24-26 September at JW Marriott Hotel Kuala Lumpur, Malaysia. The event is supported by the Malaysian Communications and Multimedia Commission (MCMC) and also the Malaysia Convention and Exhibition Bureau (MyCEB). Host sponsor for the event is Axiata with other event sponsors including Fiberhome (Headline Sponsor), Edotco, Gigabyte, Huawei and Telepin (Industry Sponsors), as well as Arm (eSim Supporting Sponsor).
“We are excited to bring the Mobile 360 – Digital Societies event to Malaysia for the first time as mobile technology is no doubt playing a pivotal role in driving economic development in the Asia Pacific Region,” said, John Hoffman, CEO, GSMA Ltd. “This three-day event will provide a perfect platform for stakeholders to share their experiences and expand the positive impact of mobile throughout this vibrant and diverse region.”
Keynote Speakers
At the event, industry-leading speakers will shine a light on APAC innovation examining how developments in these core areas are powering digital transformation across the region. Speakers confirmed to present at Mobile 360 – Digital Societies include:
- Gobind Singh Deo, Minister of Communication and Multimedia, Malaysia
- YBrs. Encik Al-Ishsal Ishak, Chairman, Malaysian Communications and Multimedia Commission
- Sok Puthyvuth, Secretary of State, Cambodia MPTC
- Tony Fernandes, CEO, AirAsia Group
- Dr Hans Wijayasuriya, Corporate EVP and Regional CEO, South Asia, Axiata
- Loke Hwee Wong, VP, APAC, Boku
- Teddy Oetomo, CSO, Bukalapak
- Michael Patent, CEO, Culture Group
- Albern Murty, CEO, Digi Telecommunications
- Suresh Sidhu, CEO, edotco
- Wang Xiaofei, CMO, Fiberhome
- Louise Easterbrook, CFO, GSMA
- Khoo Yuen Hing, CTO, Huawei
- Masayoshi Sakai, Counsellor, Information-technology Promotion Agency, Japan
- Sohee Shin, SVP, Global Business Unit and Global Alliance Division, KT
- Gokhan Ogut, CEO, Maxis Broadband Sdn Bhd
- Maya Arvini, CCO, Qlue
- Takeshi Fukuizumi, Head of Fintech and Blockchain, Softbank
- Foong Yuh Wen, CEO and Founder, Sushivid
- Anthony Socci, President and General Manager, APAC, Synchronoss
- Vince Kadar, CEO, Telepin
- Brad Jones, CEO, Wave Money
- Kaspar Tiri, Co-Founder, Wolf 3D
- David An, CTO, ZTE Group Asia
The full conference agenda is available at https://www.mobile360series.com/digital-societies/agenda/ .
In addition to the keynotes, a series of in-depth workshops and sessions will allow a deeper dive into the industry’s most complex challenges looking at topics such as Forging Digital Societies Through Digital Platforms , Building Simple, Clear and Fast Public Services and 5G and Digitalisation . Mobile 360 – Digital Societies will examine the attributes that contribute to a successful digital society. Focusing on the digital platforms enabling new and innovative services, the event highlights the key elements that define a successful digital society including citizenship, commerce, identity, lifestyle and connectivity, and how developments in these key areas can lead to gains for society as a whole.
Women4Tech Leaders Reception
Mobile 360 – Digital Societies will host the first Women4Tech Leaders Reception in APAC on 24 September 2019 from 5:30pm-7:30pm. The event will stimulate discussion on the benefits of encouraging gender diversity in the tech industry and addressing what can be done about the current gender gap through education and public policy. It will also look at ways to promote gender diversity culture in business organisations.
Registration for Women4Tech Leaders Reception is available here: www.mobile360series.com/digital-societies/agenda/apply-to-attend-workshop/#contact
Registration for Mobile 360 – Digital Societies is now open; individuals wishing to attend should visit www.mobile360series.com/digital-societies/attend/attendee-registration/ . For further information on Mobile 360 – Digital societies, please visit: www.mobile360series.com/digital-societies/overview/ . Further information on the entire Mobile 360 Series of events is available at www.mobile360series.com/ . Follow developments and updates on Mobile 360 Series (#mobile360) on Twitter @GSMA and on Facebook www.facebook.com/Mobile360Series .
-ENDS-
About the GSMA
The GSMA represents the interests of mobile operators worldwide, uniting more than 750 operators and nearly 400 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces the industry-leading MWC events held annually in Barcelona, Los Angeles and Shanghai, as well as the Mobile 360 Series of regional conferences.
For more information, please visit the GSMA corporate website at www.gsma.com . Follow the GSMA on Twitter: @GSMA .
View source version on businesswire.com: https://www.businesswire.com/news/home/20190909005062/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom